BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND PBX1, P40424, 5087
333 results:

  • 1. Extracellular matrix protein 1 (ECM1) is a potential biomarker in B cell acute lymphoblastic leukemia.
    Wu LX; Zhao MY; Yan N; Zhou YL; Cao LM; Qin YZ; Jiang Q; Xu LP; Zhang XH; Huang XJ; Jiang H; Ruan GR
    Clin Exp Med; 2024 Mar; 24(1):56. PubMed ID: 38546916
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. CircRNAome of Childhood Acute Lymphoblastic Leukemia: Deciphering Subtype-Specific Expression Profiles and Involvement in
    Gutierrez-Camino A; Caron M; Richer C; Fuchs C; Illarregi U; Poncelet L; St-Onge P; Bataille AR; Tremblay-Dauphinais P; Lopez-Lopez E; Camos M; Ramirez-Orellana M; Astigarraga I; Lécuyer É; Bourque G; Martin-Guerrero I; Sinnett D
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338754
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Transcriptome Sequencing Allows Comprehensive Genomic Characterization of Pediatric B-Acute Lymphoblastic Leukemia in an Academic Clinical Laboratory.
    Hu Z; Kovach AE; Yellapantula V; Ostrow D; Doan A; Ji J; Schmidt RJ; Gu Z; Bhojwani D; Raca G
    J Mol Diagn; 2024 Jan; 26(1):49-60. PubMed ID: 37981088
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Presence of leukemic clone-specific immunoglobulin heavy chain rearrangements in neonatal blood spots of children with B-cell precursor acute lymphoblastic leukemia.
    Kacanski N; Kolarovic J; Kostic T; Marjanovic I; Janic D; Pavlovic S; Karan-Djurasevic T
    Int J Lab Hematol; 2024 Apr; 46(2):303-311. PubMed ID: 37929321
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. MEIS inhibitors reduce the viability of primary leukemia cells and Stem cells by inducing apoptosis.
    Meriç N; Albayrak E; Gülbaş Z; Kocabaş F
    Leuk Lymphoma; 2024 Feb; 65(2):187-198. PubMed ID: 37902585
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Clinical Significance of Minimal Residual Disease in Pediatric Patients with
    Xue YJ; Lu AD; Wang Y; Jia YP; Zuo YX; Zhang LP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1303-1308. PubMed ID: 37846676
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A surrogate molecular approach for the detection of Philadelphia chromosome-like B-acute lymphoblastic leukemia.
    Gupta DG; Varma N; Abdulkadir SA; Sreedharanunni S; Sachdeva MUS; Naseem S; Bose P; Binota J; Malhotra P; Khadwal A; Trehan A; Varma S
    Cancer; 2024 Mar; 130(5):713-726. PubMed ID: 37819686
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Molecular characterization of TCF3::pbx1 chromosomal breakpoints in acute lymphoblastic leukemia and their use for measurable residual disease assessment.
    Burmeister T; Gröger D; Gökbuget N; Spriewald B; Starck M; Elmaagacli A; Hoelzer D; Keller U; Schwartz S
    Sci Rep; 2023 Sep; 13(1):15167. PubMed ID: 37704696
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. BRD4 PROTAC degrader MZ1 exhibits anti-B-cell acute lymphoblastic leukemia effects via targeting CCND3.
    Ma L; Wang J; Yang Y; Lu J; Ling J; Chu X; Zhang Z; Tao Y; Li X; Tian Y; Li Z; Zhang Y; Sang X; Lu L; Wan X; Zhang K; Chen Y; Yu J; Zhuo R; Wu S; Pan J; Zhou X; Hu Y; Hu S
    Hematology; 2023 Dec; 28(1):2247253. PubMed ID: 37594294
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Leukemia Genotype Analysis of Children with Acute Lymphoblastic Leukemia in Yunnan Area].
    Shi SL; Kui LY; Xia SM; Zhou BL; Li RJ; Jiang HC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):980-984. PubMed ID: 37551465
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Establishment of the lymphoid ETS-code reveals deregulated ETS genes in Hodgkin lymphoma.
    Nagel S; Meyer C; Pommerenke C
    PLoS One; 2023; 18(7):e0288031. PubMed ID: 37428779
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Transcription factor abnormalities in B-ALL leukemogenesis and treatment.
    Yin H; Wang J; Tan Y; Jiang M; Zhang H; Meng G
    Trends Cancer; 2023 Oct; 9(10):855-870. PubMed ID: 37407363
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Emerging molecular subtypes and therapies in acute lymphoblastic leukemia.
    Davis K; Sheikh T; Aggarwal N
    Semin Diagn Pathol; 2023 May; 40(3):202-215. PubMed ID: 37120350
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. TCF3 gene rearrangements in pediatric B-cell acute lymphoblastic leukemia-A single center experience.
    Zerkalenkova E; Menchits Y; Borkovskaia A; Sokolova S; Soldatkina O; Mikhailova E; Popov A; Komkov A; Rumiantseva Y; Karachunskii A; Olshanskaya Y
    Int J Lab Hematol; 2023 Aug; 45(4):533-540. PubMed ID: 37058324
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Etiology of oncogenic fusions in 5,190 childhood cancers and its clinical and therapeutic implication.
    Liu Y; Klein J; Bajpai R; Dong L; Tran Q; Kolekar P; Smith JL; Ries RE; Huang BJ; Wang YC; Alonzo TA; Tian L; Mulder HL; Shaw TI; Ma J; Walsh MP; Song G; Westover T; Autry RJ; Gout AM; Wheeler DA; Wan S; Wu G; Yang JJ; Evans WE; Loh M; Easton J; Zhang J; Klco JM; Meshinchi S; Brown PA; Pruett-Miller SM; Ma X
    Nat Commun; 2023 Apr; 14(1):1739. PubMed ID: 37019972
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Mitotic recombinatory evolution in acute leukemia.
    Papenhausen P; Kelly CA; Zhang Z; Penton A
    Cancer Genet; 2023 Jun; 274-275():33-40. PubMed ID: 36966725
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Prognostic factors of childhood acute lymphoblastic leukemia with TCF3::pbx1 in CCCG-ALL-2015: A multicenter study.
    Zhang H; Wan Y; Wang H; Cai J; Yu J; Hu S; Fang Y; Gao J; Jiang H; Yang M; Liang C; Jin R; Tian X; Ju X; Hu Q; Jiang H; Li Z; Wang N; Sun L; Leung AWK; Wu X; Qian X; Qian M; Li CK; Yang J; Tang J; Zhu X; Shen S; Zhang L; Pui CH; Zhai X
    Cancer; 2023 Jun; 129(11):1691-1703. PubMed ID: 36943767
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Classification and genetics of pediatric B-other acute lymphoblastic leukemia by targeted RNA sequencing.
    Migita NA; Jotta PY; Nascimento NPD; Vasconcelos VS; Centoducatte GL; Massirer KB; Azevedo AC; Brandalise SR; Yunes JA
    Blood Adv; 2023 Jul; 7(13):2957-2971. PubMed ID: 36848637
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Disruption to the FOXO-PRDM1 axis resulting from deletions of chromosome 6 in acute lymphoblastic leukaemia.
    Sinclair PB; Cranston RE; Raninga P; Cheng J; Hanna R; Hawking Z; Hair S; Ryan SL; Enshaei A; Nakjang S; Rand V; Blair HJ; Moorman AV; Heidenreich O; Harrison CJ
    Leukemia; 2023 Mar; 37(3):636-649. PubMed ID: 36670235
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Clinical features and prognosis of high hyperdiploid childhood acute lymphoblastic leukemia: a multicenter retrospective analysis in Fujian Province, China].
    Cai CX; Zheng YZ; Li J; Wen H; Weng KZ; Zhuang SQ; Wu XG; LE SH
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Jan; 25(1):38-45. PubMed ID: 36655662
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 17.